Aromatase and other steroidogenic genes in endometriosis: translational aspects.
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Endometriosis is a common, chronic and estrogen-dependent gynaecological disorder associated with pelvic pain and infertility. In addition to, or perhaps as a consequence of, immune, environmental and genetic factors, endometriotic lesions show high estradiol (E2) biosynthesis and low E2 inactivation compared with normal endometrium. Current medical therapies of pain, which aim to lower circulating E2 concentrations, are not effective in at least half of these patients. We and others recently demonstrated the expression of a few steroidogenic genes in endometriosis. The most important genes in this group are steroidogenic acute regulatory protein (StAR) and aromatase. Both are essential for E2 production. Prostaglandin E2 (PGE2) is the most potent known stimulator of both StAR and aromatase. PGE2 production in endometriosis is up-regulated by increased levels of the enzyme cyclo-oxygenase-2 (COX-2) in this tissue. COX-2 in turn is stimulated by E2, interleukin-1β (IL-1β) and PGE2 itself in endometrial and endometriotic cells. Thus, there is a positive feedback loop that favours continuous formation of E2 and PGE2 in endometriosis. These basic findings led to recent phase-II studies employing aromatase inhibitors in the treatment of endometriosis. Aromatase inhibitors treat both postmenopausal and premenopausal endometriosis at least as effectively as the existing medical treatments. In premenopausal women, we and others administered aromatase inhibitors in combination with an ovarian-suppressant treatment. In this review, we emphasize the most recent basic studies in detail and provide a short summary of recent clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there are a number of reports that aromatase is expressed in endometriosis lesions with evidence of a positive feed-forward loop involving local biosynthesis of both E2 and the pro-inflammatory regulator prostaglandin E2 [69,98].”
From Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders (2018) · cites this paper as [69]
In the citing paper
“there are a number of reports that aromatase is expressed in endometriosis lesions with evidence of a positive feed-forward loop involving local biosynthesis of both E2 and the pro-inflammatory regulator prostaglandin E2 [69,98].”
From Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders (2018) · cites this paper as [69]
In the citing paper
“PGE 2 is the most potent known stimulator of P450arom in endometriotic stromal cells (10,13,15).”
From Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis (2009) · cites this paper as [15]
In the citing paper
“The similarity of the molecular biology of TIAR in various tissues with that described in endometriosis [39–41, 59–62] strongly suggests that this represents the common underlying mechanisms of both processes”
From The pathophysiology of endometriosis and adenomyosis, tissue injury and repair (2009) · cites this paper as [61]
In the citing paper
“The recent evidence that women, despite the hypogonatrophic effect obtained from combined oral contraceptives (COCs), have increased hormone levels in endometriosis implants compared to controls ( 61 )”
From Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism (2022) · cites this paper as [61]
Citations
Cites
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Aromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., MAHENDROO, M. S., MEANS, G. D., KILGORE, M. W., HINSHELWOOD, M. M., GRAHAM-LORENCE, S., AMARNEH, B., ITO, Y., FISHER, C. R., MICHAEL, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,537
Self-citationSource of Estrogen Production in Postmenopausal Women1
GRODIN, J. M., SIITERI, P. K., & MACDONALD, P. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-2-207 · Cited by 959
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., Speed, C., & Jones, M. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081601.142703 · Cited by 773
Kao, L. C., Germeyer, A., Tulac, S., Lobo, S., Yang, J. P., Taylor, R. N., Osteen, K., Lessey, B. A., & Giudice, L. C. (2003) · Endocrinology · doi:10.1210/en.2003-0043 · Cited by 696 · cited 2×
“…endometriosis exhibits multiple molecular abnormalities that may be linked to aberrant production of estrogen, PGs, cytokines and decreased production of molecules important for decidual transformation of stromal cells (Lessey et al., 1994; Tseng et al., 1996; Kao et al., 2003; Wu et al., 2005).”
BackgroundResultAromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 5×
“…and expression of protein and mRNA in the stromal cell component of endometriosis, whereas StAR or aromatase expression was either absent or barely detectable in the eutopic endometrium of disease-free women (Noble et al., 1996, 1997; Tsai et al., 2001; Gurates et al., 2002; Sun et al., 2003).”
BackgroundInfluentialSelf-citationStocco, D. M., Wang, X., Jo, Y., & Manna, P. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0532 · Cited by 538
Aberrant integrin expression in the endometrium of women with endometriosis
Lessey, B. A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.643 · Cited by 514
Zhao, Y. D., Agarwal, V. R., Mendelson, C. R., & Simpson, E. R. (1996) · Endocrinology · doi:10.1210/en.137.12.5739 · Cited by 434
Research works printed but not linked: 9
- Bulun, 1994, J Clin Endocrinol Metab, 78, 428
- Lessey, 1994, J Clin Endocrinol Metab, 79, 643
- Noble, 1996, J Clin Endocrinol Metab, 81, 174
- Noble, 1997, J Clin Endocrinol Metab, 82, 600
- Ryan, 1994, J Clin Endocrinol Metab, 78, 642
- Simpson, 1994, Endocr Rev, 15, 342
- Tamura, 2002, J Clin Endocrinol Metab, 87, 3263
- Tseng, 1996, J Clin Endocrinol Metab, 81, 1118
- Yang, 2002, J Clin Endocrinol Metab, 87, 2336
Cited by
Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425
The pathophysiology of endometriosis and adenomyosis, tissue injury and repair
Leyendecker, G., Wildt, L., & Mall, G. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1191-0 · Cited by 418
“endometriosis [39–41, 59–62] strongly suggests that this represents the common underlying mechanisms of both processes (Fig.”
BackgroundPathogenic mechanisms in endometriosis-associated infertility
Gupta, S., Goldberg, J. M., Aziz, N., Goldberg, E., Krajcir, N., & Agarwal, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.093 · Cited by 409
Pathophysiology and Immune Dysfunction in Endometriosis
Ahn, S. H., Monsanto, S. P., Miller, C., Singh, S. S., Thomas, R., & Tayade, C. (2015) · BioMed Research International · doi:10.1155/2015/795976 · Cited by 397
Contemporary genetic technologies and female reproduction
The Evian Annual Reproduction (EVAR) Workshop Group 2010, Fauser, B. C. J. M., Diedrich, K., Bouchard, P., Dominguez, F., Matzuk, M., Franks, S., Hamamah, S., Simon, C., Devroey, P., et al. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr033 · Cited by 349
Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis1
Xue, Q., Lin, Z., Cheng, Y.-H., Huang, C.-C., Marsh, E., Yin, P., Milad, M. P., Confino, E., Reierstad, S., Innes, J., et al. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.061804 · Cited by 346
Self-citationPathophysiological implications of hypoxia in human diseases
Chen, P.-S., Chiu, W.-T., Hsu, P.-L., Lin, S.-C., Peng, I.-C., Wang, C.-Y., & Tsai, S.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00658-7 · Cited by 318
Xue, Q., Lin, Z., Yin, P., Milad, M. P., Cheng, Y.-H., Confino, E., Reierstad, S., & Bulun, S. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0494 · Cited by 219
Self-citationAttar, E., Tokunaga, H., Imir, G., Yilmaz, M. B., Redwine, D., Putman, M., Gurates, B., Attar, R., Yaegashi, N., Hales, D. B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1180 · Cited by 207
Self-citationBacterial contamination hypothesis: a new concept in endometriosis
Khan, K. N., Fujishita, A., Hiraki, K., Kitajima, M., Nakashima, M., Fushiki, S., & Kitawaki, J. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12083 · Cited by 176
“coli or by its indirect immunosuppression effect on peripheral blood lymphocytes39 and (2) the decreased expression of antimicrobial peptides, such as human β- defensin (HBD) and/or secretory leukocyte protease inhibitor (SLPI), in the endometrium.”
BackgroundDual suppression of estrogenic and inflammatory activities for targeting of endometriosis
Zhao, Y., Gong, P., Chen, Y., Nwachukwu, J. C., Srinivasan, S., Ko, C., Bagchi, M. K., Taylor, R. N., Korach, K. S., Nettles, K. W., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010626 · Cited by 170
Estrogen metabolism and action in endometriosis
Rižner, T. L. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.03.022 · Cited by 153
Cellular and molecular basis for endometriosis-associated infertility
Stilley, J. A. W., Birt, J. A., & Sharpe-Timms, K. L. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1309-0 · Cited by 151
A new concept of endometriosis and adenomyosis, tissue injury and repair (TIAR)
Leyendecker, G., & Wildt, L. (2011) · hmbci · doi:10.1515/hmbci.2011.002 · Cited by 147
Dull, A.-M., Moga, M. A., Dimienescu, O. G., Sechel, G., Burtea, V., & Anastasiu, C. V. (2019) · Molecules · doi:10.3390/molecules24040667 · Cited by 141
Aromatase inhibitors for the treatment of endometriosis
Pavone, M. E., & Bulun, S. E. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.053 · Cited by 138
“In the ovary, the biologically active estradiol is produced from cholesterol through serial enzymatic actions in two cell types, namely the theca and granulosa cells, which cooperate in a paracrine fashion (Figure 1) (1, 17).”
BackgroundInfluentialSelf-citationEstrogen biosynthesis and signaling in endometriosis
Huhtinen, K., Ståhle, M., Perheentupa, A., & Poutanen, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.022 · Cited by 107
Endometriosis and polycystic ovary syndrome are diametric disorders
Dinsdale, N. L., & Crespi, B. J. (2021) · Evolutionary Applications · doi:10.1111/eva.13244 · Cited by 90
Hypoxia: The force of endometriosis
Wu, M., Hsiao, K., & Tsai, S. (2019) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.13900 · Cited by 88
Sofo, V., Götte, M., Laganà, A. S., Salmeri, F. M., Triolo, O., Sturlese, E., Retto, G., Alfa, M., Granese, R., & Abrão, M. S. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3739-5 · Cited by 88
The Expression and Ovarian Steroid Regulation of Endometrial Micro-RNAs
Toloubeydokhti, T., Pan, Q., Luo, X., Bukulmez, O., & Chegini, N. (2008) · Reproductive Sciences · doi:10.1177/1933719108324132 · Cited by 83
“Cyclooxygenase 2 is also expressed by the endometrial tissues and cells, and PGE2 or a cAMP analogue has been shown to induce StAR and aromatase expression and activity in the endometriotic stromal cells.(5) We also found an elevated expression of CYP19A1, StAR, and COX-2 in EC as compared to EU and EN; however, their…”
BackgroundResultInfluentialRetractedAndrogens, oestrogens and endometrium: a fine balance between perfection and pathology
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0106 · Cited by 76
Evolution of medical treatment for endometriosis: back to the roots?
Wieser, F., Cohen, M., Gaeddert, A., Yu, J., Burks-Wicks, C., Berga, S. L., & Taylor, R. N. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm015 · Cited by 76
Huhtinen, K., Saloniemi-Heinonen, T., Keski-Rahkonen, P., Desai, R., Laajala, D., Ståhle, M., Häkkinen, M. R., Awosanya, M., Suvitie, P., Kujari, H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1913 · Cited by 75
Occult microscopic endometriosis: undetectable by laparoscopy in normal peritoneum
Khan, K. N., Fujishita, A., Kitajima, M., Hiraki, K., Nakashima, M., & Masuzaki, H. (2014) · Human Reproduction · doi:10.1093/humrep/det438 · Cited by 72
“There are some established hypotheses and regulatory factors supporting the development or maintenance of endometriosis (Attar and Bulun, 2006; Burney and Giudice, 2012).”
BackgroundHudelist, G., Czerwenka, K., Keckstein, J., Haas, C., Fink-Retter, A., Gschwantler-Kaulich, D., Kubista, E., & Singer, C. F. (2007) · Reproductive Sciences · doi:10.1177/1933719107309120 · Cited by 70
Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103276 · Cited by 70
“Local oestrogen production, accompanied by intracrine and paracrine signalling via ERbeta in endometriotic tissues is believed to contribute to a feed-forward signalling cascade that maintains an inflammatory state and cell proliferation within the endometriotic lesions (for a comprehensive review on the role of oestr…”
BackgroundShen, L., Yang, S., Huang, W., Xu, W., Wang, Q., Song, Y., & Liu, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3010 · Cited by 57
Xue, Q., Zhou, Y. F., Zhu, S. N., & Bulun, S. E. (2011) · Reproductive Sciences · doi:10.1177/1933719111404614 · Cited by 50
Self-citationEpigenetic aberration of gene expression in endometriosis
Izawa, M. (2013) · Frontiers in Bioscience · doi:10.2741/e669 · Cited by 49
González-Fernández, R., Peña, Ó., Hernández, J., Martín-Vasallo, P., Palumbo, A., & Ávila, J. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.030 · Cited by 48
Estrogen and progesterone receptors in smooth muscle component of deep infiltrating endometriosis
Noël, J.-C., Chapron, C., Bucella, D., Buxant, F., Peny, M.-O., Fayt, I., Borghese, B., & Anaf, V. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.12.114 · Cited by 41
Hsu, C.-C., Lu, C.-W., Huang, B.-M., Wu, M.-H., & Tsai, S.-J. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080199 · Cited by 30
Tian, Y., Kong, B., Zhu, W., Su, S., & Kan, Y. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700513 · Cited by 25
Othman, E. E.-D. R., Hornung, D., & Al-Hendy, A. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.7.741 · Cited by 18
Mercorio, A., Giampaolino, P., Romano, A., Dällenbach, P., & Pluchino, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.950866 · Cited by 16
“The recent evidence that women, despite the hypogonatrophic effect obtained from combined oral contraceptives (COCs), have increased hormone levels in endometriosis implants compared to controls (61) highlights the crucial role of intracrinology as a mechanism of endometriosis development and drug resistance.”
BackgroundDe Abreu, L. G., Silveira, V. S., Scrideli, C. A., Ramos, E. S., Dos Reis, R. M., Ferriani, R. A., & De Sá, M. F. S. (2011) · Journal of Endometriosis · doi:10.5301/je.2012.9070 · Cited by 11
Naem, A., Krentel, H., Moawad, G., Naem, J., Venezia, R., Etrusco, A., Terzic, S., & Laganà, A. S. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102500 · Cited by 15
Lousse, J.-C., Defrère, S., Ramos, R. G., Van Langendonckt, A., Colette, S., & Donnez, J. (2009) · Journal of Endometriosis · doi:10.1177/228402650900100104 · Cited by 10
“Aromatase gives rise to the synthesis of estrogen, which in turn impacts positively on COX-2 enzyme expression and further prostaglandin synthesis (57).”
Background
Metadata
- Authors
- Attar, E., & Bulun, S. E.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Attar, E.
- ORCID
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-25
- Volume
- 12
- Issue
- 1
- Pages
- 49-56
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2143048167
- Semantic Scholar
- 3b4b43f8e922c94c2584dcd15b01db33ae2eb42c
- Cited by
- 255
- References
- 60
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 9 · 2023: 9 · 2022: 11 · 2021: 15 · 2020: 9 · 2019: 12 · 2018: 4 · 2017: 9 · 2016: 8 · 2015: 17 · 2014: 15 · 2013: 11 · 2012: 17
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 36891)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- endometriosis, aromatase, steroidogenic genes, steroidogenic acute regulatory protein, estradiol synthesis, prostaglandin E2, cyclooxygenase-2, IL-1β, aromatase inhibitors, ovarian suppression, estrogen-dependent disease, infertility, pelvic pain
- MeSH terms
- Steroidogenic Acute Regulatory Protein, Aromatase, Cells, Cultured, Endometriosis, Estrogens, Female, Humans, Inflammation, Phosphoproteins, Steroids, Protein Biosynthesis, Dinoprostone, Signal Transduction, Gene Expression Regulation, Enzymologic, Stromal Cells, Aromatase Inhibitors, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.